Guanine and inosine nucleotides/nucleosides suppress murine T cell activation

Area of Science:

• Immunology
• Cell Signaling

Background:

• Intracellular purine nucleotides act as intercellular signaling factors released from damaged cells.
• Previous research indicated that adenosine triphosphate (ATP) suppresses murine splenic T lymphocyte activation.

Purpose of the Study:

• To investigate the effects of various purine nucleotides and nucleosides on mouse T cell activation.
• To determine if guanine and inosine derivatives can modulate T cell responses and cytokine production.

Main Methods:

• Mouse spleen T cells were pretreated with various purine nucleotides/nucleosides (GTP, GDP, GMP, guanosine, ITP, IDP, IMP, inosine) at 250 μM.
• Cytokine release (IL-2, IL-6) and CD25 expression were measured.
• ERK1/2 phosphorylation was assessed to evaluate signaling pathways.

Main Results:

• Pretreatment with GTP, GDP, GMP, guanosine, ITP, IDP, IMP, or inosine significantly reduced interleukin-2 (IL-2) release.
• Guanine and inosine derivatives also suppressed interleukin-6 (IL-6) release.
• Suppression of cytokine release was not due to cell death and did not involve inhibition of ERK1/2 phosphorylation.
• Unlike ATP, guanine or inosine compounds did not affect CD25 expression.

Conclusions:

• Exogenous guanine and inosine nucleotides/nucleosides effectively suppress inflammatory cytokine release from T cells.
• These compounds do not induce T cell death or inhibit key signaling pathways like ERK1/2.
• Guanine and inosine derivatives show potential as supplementary treatments for T cell-mediated immune diseases.